SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 183 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $252,000 | +13.5% | 9,205 | +59.8% | 0.00% | 0.0% |
| Q4 2015 | $222,000 | -5.9% | 5,760 | -21.6% | 0.00% | 0.0% |
| Q3 2015 | $236,000 | -35.3% | 7,349 | -38.8% | 0.00% | -33.3% |
| Q2 2015 | $365,000 | +69.0% | 12,000 | -26.3% | 0.00% | +50.0% |
| Q1 2015 | $216,000 | -65.0% | 16,276 | -61.9% | 0.00% | -60.0% |
| Q4 2014 | $618,000 | -21.7% | 42,702 | +14.2% | 0.01% | -50.0% |
| Q3 2014 | $789,000 | +112.7% | 37,380 | +142.1% | 0.01% | +233.3% |
| Q1 2014 | $371,000 | – | 15,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |